Media – Britannia Pharm

Stay connected

Welcome to the Britannia Pharmaceuticals media centre

We are committed to giving relevant, accurate and timely information to all appropriate stakeholders.

We welcome enquiries from media, patients and any other interested parties – and are happy to answer questions and participate in discussions around our specialist disease areas.

For all media enquiries, please email [email protected]

October Internal Developments

We are delighted to share our latest internal developments within the Britannia team. Sharmin Shah

26th October 2020

Britannia-STADA expands specialty footprint through acquisition of innovative therapy for treating Parkinson’s disease.

Press Release STADA is submitting applications for approval to launch the new therapy in major

5th October 2020

Charity Partnership 2020

Britannia are pleased to announce our new partnership with local charity Daisy’s Dream; a professional

19th May 2020

HSJ Partnership Nomination

The 2020 HSJ Partnership Awards will be held on the evening of 27 February at

26th February 2020

MDS Congress, September 2019

Britannia were thrilled to attend the International Congress of Parkinson’s Disease and Movement Disorders in

30th September 2019

Britannia support Mental Health Awareness by holding ‘Wellbeing Week’

This marks Britannia’s second year of holding wellbeing events during Mental Health awareness week. This

15th May 2019

World Parkinson’s Day

Thursday 11th April 2019 marks World Parkinson’s Day; a day to recognise and raise awareness

11th April 2019

Britannia Continues Charity Partnership with SANE

In 2018, Britannia Pharmaceuticals launched our first ever charity partnership with UK mental health charity,

7th February 2019

Employee Engagement Nomination

The 2018 Personnel Today Awards will be held on the evening of 21 November at

21st August 2018

Links

Contact

+44(0)1189 209 500
200 Longwater Ave, Green Park, Reading, Berkshire, RG2 6GP

Connect with us

© Copyright 2021 Britannia Pharmaceuticals

Job Code BRIT-0720-11423
Date of Preparation: March 2021

Britannia Pharmaceuticals Ltd, a company registered in England and Wales. Registered Office: 200 Longwater Avenue, Green Park, Reading, Berkshire RG2 6GP.
Registered No. 01557088